https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-25 16:36:202016-11-25 16:38:002012 ASH: Results from Dose Escalation Phase of Randomized Phase 1-2 FIH Study of SGI-110
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-23 16:38:392016-11-25 16:38:582012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-20 16:39:062016-11-25 16:39:262012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-15 16:39:312016-11-25 16:39:522012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
